In a cohort study, researchers observed a significant decrease in incident reinfection among patients with Hepatitis C who received increased follow-up after achieving sustained virologic response.
Individuals with acute hepatic porphyria often experience acute attacks and chronic symptoms which greatly diminish their quality of life. Researchers examined the efficacy of givosiran in reducing these...
The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
Many patients with chronic hepatitis B virus (HBV) are experiencing improved outcomes thanks to the advent of antiviral therapies. However, not all patients with chronic HBV have been considered candidates...
Previous studies have shown widely varying estimates of the incidence of nonalcoholic fatty liver disease (NAFLD) in lean and nonobese individuals. In a new study, researchers sought to narrow that range...
